SciClone Pharmaceuticals (Holdings)'s quarterly market cap
increased
from Dec. 2022 (HK$5,760 Mil) to Jun. 2023 (HK$6,521 Mil) and
increased
from Jun. 2023 (HK$6,521 Mil) to Dec. 2023 (HK$8,727 Mil).
SciClone Pharmaceuticals (Holdings)'s annual market cap
declined
from Dec. 2021 (HK$5,812 Mil) to Dec. 2022 (HK$5,760 Mil) but then
increased
from Dec. 2022 (HK$5,760 Mil) to Dec. 2023 (HK$8,727 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. SciClone Pharmaceuticals (Holdings)'s Enterprise Value for Today is HK$9,280 Mil.
SciClone Pharmaceuticals (Holdings) Market Cap Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
SciClone Pharmaceuticals (Holdings) Market Cap Chart
Competitive Comparison of SciClone Pharmaceuticals (Holdings)'s Market Cap
For the Drug Manufacturers - Specialty & Generic subindustry, SciClone Pharmaceuticals (Holdings)'s Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
SciClone Pharmaceuticals (Holdings)'s Market Cap Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, SciClone Pharmaceuticals (Holdings)'s Market Cap distribution charts can be found below:
* The bar in red indicates where SciClone Pharmaceuticals (Holdings)'s Market Cap falls into.
SciClone Pharmaceuticals (Holdings) Market Cap Calculation
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SciClone Pharmaceuticals (Holdings) (HKSE:06600) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
SciClone Pharmaceuticals (Holdings) Market Cap Related Terms
Thank you for viewing the detailed overview of SciClone Pharmaceuticals (Holdings)'s Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.
SciClone Pharmaceuticals (Holdings) (HKSE:06600) Business Description
SciClone Pharmaceuticals (Holdings) Ltd is a biopharmaceutical company with an integrated platform for product development and commercialization. It strategically focuses on some of the fast-growing therapeutic areas with unmet medical needs in China, primarily including oncology and severe infection. It generated revenue primarily from the sale of Zadaxin to Sinopharm.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
HKSE:06600 has been successfully added to your 